Protein Expression Analysis in Hematopoietic Stem Cells during Osteopontin-Induced Differentiation of Natural Killer Cells
![]() ![]() |
Kim, Mi-Sun
(Cell Therapy Research Center, Korea Research Institute of Bioscience and Biotechnology)
Bae, Kil-Soo (Department of Biological Science, Dong-A University) Kim, Hye-Jin (Department of Biological Science, Dong-A University) Yoon, Suk-Ran (Cell Therapy Research Center, Korea Research Institute of Bioscience and Biotechnology) Oh, Doo-Byung (Aging Research Center, Korea Research Institute of Bioscience and Biotechnology) Hwang, Kwang-Woo (Department of Immunology, College of Pharmacy, Chung Ang University) Jun, Woo-Jin (Department of Food and Nutrition, Chonnam National University) Shim, Sang-In (Department of Agronomy, Gyeongsang National University) Kim, Kwang-Dong (Division of Applied Life Science (BK21), Gyeongsang National University) Jung, Yong-Woo (Department of Immunology, College of Pharmacy, Korea University Sejong Campus) Park, So-Young (Department of Nanobiomedical Science, Dankook University) Kwon, Ki-Sun (Aging Research Center, Korea Research Institute of Bioscience and Biotechnology) Choi, In-Pyo (Cell Therapy Research Center, Korea Research Institute of Bioscience and Biotechnology) Chung, Jin-Woong (Department of Biological Science, Dong-A University) |
1 | Ostiguy, V., Allard, E. L., Marquis, M., Leignadier, J. and Labrecque, N. (2007) IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J. Leukoc. Biol. 82, 645-656. DOI |
2 | Perussia, B. (1996) The cytokine profile of resting and activated NK cells. Methods 9, 370-378. DOI |
3 | Robertson, B. W., Bonsal, L. and Chellaiah, M. A. (2010) Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells, Molecular Cancer 9, 260. DOI |
4 | Schack, L., Stapulionis, R., Christensen, B., Kofod-Olsen, E., Skov Sorensen, U. B., Vorup-Jensen, T., Sorensen, E. S. and Hollsberg, P. (2009) Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin, J Immunol. 182, 6943-6950. DOI |
5 | Sheridan, C., Brumatti, G., Elgendy, M., Brunet, M. and Martin, S. J. (2010) An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. Oncogene. 29, 6428-6441. DOI |
6 | Stier, S., Ko, Y., Forkert, R., Lutz, C., Neuhaus, T., Grunewald, E., Cheng, T., Dombkowski, D., Calvi, L. M., Rittling, S. R. and Scadden D. T. (2005) Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781-1791. DOI |
7 | Veronique Orian-Rousseau. (2010) CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer 46, 1271-1277. DOI |
8 | Bonanno, G., Mariotti, A., Procoli, A., Corallo, M., Scambia, G., Pierelli, L. and Rutella, S. (2009) Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells. BMC Immunol. 10, 46. DOI |
9 | Chung, J. W., Kim, M. S., Piao, Z. H., Jeong, M., Yoon, S. R., Shin, N., Kim, S. Y., Hwang, E. S., Yang, Y., Lee, Y. H., Kim, Y. S. and Choi, I. (2008) Osteopontin promotes the development of natural killer cells from hematopoietic precursor cells. Stem Cells 26, 2114-2123. DOI |
10 | Di Santo, J. P. (2006) Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257-286. DOI |
11 | El-Tanani, M. K. (2008) Role of osteopontin in cellular signaling and metastatic phenotype. Front Biosci. 1, 4276-4284. |
12 | Freud, A. G. and Caligiuri, M. A. (2006) Human natural killer cell development. Immunol. Rev. 214, 56-72. DOI |
13 | Mauchera, C., Weissingerb, E. M., Kremmerc, E., Baccarinind, M., Procykd, K., Hendersone, D. W., Wolffe, L., Kolcha, W., Kaspersf, B., Mushinskie, J. F. and Mischaka H. (1998) Activation of bcl-2 suppressible 40 and 44 kDa p38-like kinases during apoptosis of early and late B lymphocytic cell lines. FEBS Letter. 427, 29-35. DOI |
14 | Orian-Rousseau, V. (2010) CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer 46, 1271-1277. DOI |
15 | Metge, B. J., Liu, S., Riker, A. I., Fodstad, O., Samant, R. S. and Shevde, L. A. (2010) Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology 78, 75-86. DOI |
16 | Nilsson, S. K., Johnston, H. M., Whitty, G. A., Williams, B, Webb, R. J., Denhardt, D. T., Bertoncello, I, Bendall, L. J., Simmons, P. J. and Haylock, D. N. (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232-1239. DOI ScienceOn |
![]() |